Phlexglobal, the TMF Experts, Appoints New Non-Executive Chairman

AMERSHAM, England--(BUSINESS WIRE)--Phlexglobal, the specialist provider of Trial Master File (TMF) and electronic Trial Master File (eTMF) expertise, solutions and services for the life sciences industry, announces the appointment of Steven Kent as non-executive chairman.

Steven is an experienced and visionary leader with a strong operational grounding. He started his career as a qualified accountant, working in Retail and IT in progressively more senior roles. More recently Steven was at ClinPhone, which in August 2008 merged with Parexel's subsidiary company Perceptive, and Steven was asked to lead the combined business. In October 2009 he was asked to join the operational board of Parexel, where he led the low cost location strategy, played a leading part in the winning of two partnership contracts and managed the acquisition of Liquent in December 2012.

Steven now works as a non-executive chairman helping management teams of private equity backed companies grow their businesses. With Steven's vast experience in the clinical research technology space, his primary function at Phlexglobal will be to ensure robust communications between and amongst board committee chairs and to develop the strategic direction of the company.

Phlexglobal's managing director, Stella Donoghue, said: "I am delighted to welcome Steven to the board of Phlexglobal. He will add a strategic depth to our discussions and help us to develop as a business in line with our growth expectations".

About Phlexglobal

Established in 1997, Phlexglobal - The TMF Experts - are pioneers in the global provision of flexible, adaptable and technology-enabled TMF solutions & services. They offer a unique combination of Taskforce support, TMF and eTMF systems, Consulting, Training and Quality Control services that deliver clinical research support solutions to the pharmaceutical, biotechnology, medical device, and CRO and healthcare industries.

More information can be found at http://www.phlexglobal.com

Contacts

Phlexglobal Ltd
Gill Gittens
Tel: +44 (0) 1494 720420.
Email: [email protected]

 

Suggested Articles

Karen DeSalvo's appointment is the latest in a string of hires that deepen the tech giant’s investment in and focus on healthcare.

Spring Bank’s hepatitis B drug, given in tandem with Gilead’s Vemlidy, tamped down on chronic disease in 23% of patients in a phase 2 study.

Gilead names Dickinson to CFO role; MedImmune CSO Herbst nabs CSO job at Pyxis; Checkmate picks up Wooldridge for CMO.